Healthcare -
Biotechnology - NASDAQ - US
$ 9.705
0.674 %
$ 2.9 B
Market Cap
-28.54
P/E
FOLD - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities FOLD - Amicus Therapeutics, Inc.
98.1 M
LAST VALUE
11.58%
2 YEAR CAGR
22.95%
5 YEAR CAGR
14.16%
10 YEAR CAGR